XML 24 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Shareholders’ Equity - ARS ($)
$ in Millions
Share capital
Treasury shares
Inflation adjustment of share capital and treasury shares
 [1]
Share premium
Additional paid-in capital from treasury shares
Legal reserve
Special reserve Resolution CNV 609/12
 [2]
Other reserves
Retained earnings
Subtotal
Non-controlling interest
Cost of treasury shares
Changes in non-controlling interest
Reserve for currency translation adjustment
Reserve shared-based compensation
Revaluation Surplus [Member]
Special reserve
Reserve for the acquisition of securities issued by the Company
Other comprehensive income from subsidiaries
Other reserves from subsidiaries
Total other reserves
Total
Begining Balance at Jun. 30, 2017 $ 499 $ 3 $ 9,786 $ 10,592 $ 89 $ 286 $ 5,179 $ 7,113 [3] $ 19,477 $ 53,024 $ 97,860 $ (138) $ 760 $ 5,848 $ 460   $ 87 $ 9 $ 87 $ 7,113 $ 150,884
Statement Line Items [Line Items]                                            
(Loss) / profit for the year [3] 6,106 6,106 21,314                     27,420
Other comprehensive (loss) / income for the year (331) [3] (331) 17,023 (389) $ 196 (138) (331) 16,692
Total comprehensive income for the year (331) [3] 6,106 5,775 38,337 (389) 196 (138) (331) 44,112
As resolved by Ordinary and Extraordinary Shareholders' Meeting held on October                                            
Legal reserve 87 [3] (87)                    
Cash dividends [3] (1,065) (1,065)                     (1,065)
Reserve for new developments 3,947 [3] (3,947) 3,947 3,947
Purchase own shares in portfolio (17) 17 (1,779) [3] (1,779) (1,779) (1,779) (1,779)
Changes of interest in subsidiaries [3] 17                     17
Share of changes in subsidiaries' equity (2,833) [3] 105 (2,728) (2,833) (2,833) (2,728)
Reserve for share-based payments 7 [3] 7 113 7 7 120
Equity incentive plan granted 2 [3] 2                     3
Decrease due to loss of control (Note 4 (j)) [3] (16,765)                     (16,765)
Changes in non-controlling interest [3] 9,000                     9,000
Dividends distribution to non-controlling interest [3] (5,371)                     (5,371)
Capitalized contributions [3] 17                     17
Issuance of capital [3] 7                     7
Acquisition of non-controlling interest [3] 3                     3
Ending Balance at Jun. 30, 2018 482 20 9,786 10,592 91 373 5,179 6,124 [4] 20,589 53,236 123,218 (1,917) (2,073) 5,459 467 196 3,947 87 (51) 9 6,124 176,454
Statement Line Items [Line Items]                                            
Adjustments previous years (IFRS 9 and 15) (Note 2.2) [4] (201) (201) (135)                     (336)
Restated balance at Jun. 30, 2018 482 20 9,786 10,592 91 373 5,179 6,124 [4] 20,388 53,035 123,083                     176,118
Statement Line Items [Line Items]                                            
(Loss) / profit for the year [4] (26,796) (26,796) (13,933)                     (40,729)
Other comprehensive (loss) / income for the year (282) [4] (282) (522) (910) 795 (167) (282) (804)
Total comprehensive income for the year (282) [4] (26,796) (27,078) (14,455) (910) 795 (167) (282) (41,533)
As resolved by Ordinary and Extraordinary Shareholders' Meeting held on October                                            
Results/Share distribution 32,531 [4] (32,531) 32,531 32,531
Purchase own shares in portfolio (17) 17 (1,228) [4] (1,228) (1,228) (1,228) (1,228)
Distribution of dividends in shares 21 (21) [4] (535) 1,481 (1,481) (535)
Reserve for share-based payments 16 [4] 16 80 16 16 96
Changes in non-controlling interest (703) [4] (703) (775) (703) (703) (1,478)
Reversal by sale of investment properties (31) [4] 31 (31) (31)
Dividends distribution to non-controlling interest [4] 4,246                     (4,246)
Irrevocable contributions                     7                     7
Ending Balance at Jun. 30, 2019 486 16 9,786 10,592 91 373 5,179 36,427 [5] (38,908) 24,042 103,159 (1,664) (2,776) 960 4,549 483 34,997 (218) 87 9 36,427 127,201
Statement Line Items [Line Items]                                            
Adjustments previous years (IFRS 9 and 15) (Note 2.2) [5] (814) (814) (1,352)                     (2,166)
Restated balance at Jun. 30, 2019 486 16 9,786 10,592 91 373 5,179 36,427 [5] (39,722) 23,228 101,807                     125,035
Statement Line Items [Line Items]                                            
(Loss) / profit for the year [5] 3,929 3,929 16,074                     20,003
Other comprehensive (loss) / income for the year (1,508) [5] (1,508) 12,925 328 (1,565) (271) (1,508) 11,417
Total comprehensive income for the year (1,508) [5] 3,929 2,421 28,999 328 (1,565) (271) (1,508) 31,420
As resolved by Ordinary and Extraordinary Shareholders' Meeting held on October                                            
Incorporation by business combination [5] 7,442                     7,442
Treasury shares distribution 13 (13) 1,512 [5] (1,512) 1,512 1,512
Reserve for share-based payments (1) (3) [5] (4) (7) 2 (5) (3) (11)
Decrease due to loss of control (Note 4 (j)) [5] (43,301)                     (43,301)
Loss absorption (4,409) (34,997) [5] 39,406 (34,997) (34,997)
Other changes in equity [5] (61) (61) 211 (93) 16 19 58 150
Changes in non-controlling interest (425) [5] (425) 4,815 (425) (425) 4,390
Dividends distribution to non-controlling interest [5] (3,003)                     (3,003)
Capitalized contributions [5] 31                     31
Ending Balance at Jun. 30, 2020 $ 499 $ 3 $ 9,786 $ 10,592 $ 90 $ 373 $ 770 $ 1,006 [5] $ 2,040 $ 25,159 $ 96,994 $ (150) $ (3,294) $ 1,288 $ 2,984 $ 494 $ (470) $ 87 $ 67 $ 1,006 $ 122,153
[1] Includes Ps. 1 and Ps. 1 of inflation adjustment of Treasury shares as of June 30, 2020 and 2019, respectively.
[2] Related to CNV General Resolution N 609/12. See Note 19.
[3] Group's other reserves for the year ended June 30, 2018 were as follows:
[4] Group's other reserves for the year ended June 30, 2019 were as follows:
[5] Group's other reserves for the year ended June 30, 2020 were as follows: